Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Effects of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes in women versus men.

Rådholm K, Zhou Z, Clemens K, Neal B, Woodward M.

Diabetes Obes Metab. 2019 Sep 4. doi: 10.1111/dom.13876. [Epub ahead of print]

PMID:
31486272
2.

Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes Mellitus.

Figtree GA, Rådholm K, Barrett TD, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Matthews DR, Shaw W, Neal B.

Circulation. 2019 May 28;139(22):2591-2593. doi: 10.1161/CIRCULATIONAHA.119.040057. Epub 2019 Mar 17. No abstract available.

3.

C-peptide predicts all-cause and cardiovascular death in a cohort of individuals with newly diagnosed type 2 diabetes. The Skaraborg diabetes register.

Pikkemaat M, Andersson T, Melander O, Chalmers J, Rådholm K, Bengtsson Boström K.

Diabetes Res Clin Pract. 2019 Apr;150:174-183. doi: 10.1016/j.diabres.2019.03.014. Epub 2019 Mar 13.

PMID:
30878389
4.

Effect of text messaging on depression in patients with coronary heart disease: a substudy analysis from the TEXT ME randomised controlled trial.

Shariful Islam SM, Chow CK, Redfern J, Kok C, Rådholm K, Stepien S, Rodgers A, Hackett ML.

BMJ Open. 2019 Feb 20;9(2):e022637. doi: 10.1136/bmjopen-2018-022637.

5.

Response by Figtree et al to Letter Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)".

Figtree GA, Rådholm K, Neal B.

Circulation. 2019 Jan 15;139(3):418-419. doi: 10.1161/CIRCULATIONAHA.118.038477. No abstract available.

6.

Canagliflozin and Stroke in Type 2 Diabetes Mellitus.

Zhou Z, Lindley RI, Rådholm K, Jenkins B, Watson J, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Shaw W, Oh R, Desai M, Matthews DR, Neal B.

Stroke. 2019 Feb;50(2):396-404. doi: 10.1161/STROKEAHA.118.023009.

7.
8.

Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular disease, death and safety outcomes in type 2 diabetes - A systematic review.

Rådholm K, Wu JH, Wong MG, Foote C, Fulcher G, Mahaffey KW, Perkovic V, Neal B.

Diabetes Res Clin Pract. 2018 Jun;140:118-128. doi: 10.1016/j.diabres.2018.03.027. Epub 2018 Mar 28. Review.

9.

Use of the waist-to-height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE-ON study.

Rådholm K, Chalmers J, Ohkuma T, Peters S, Poulter N, Hamet P, Harrap S, Woodward M.

Diabetes Obes Metab. 2018 Aug;20(8):1903-1910. doi: 10.1111/dom.13311. Epub 2018 May 6.

PMID:
29603537
10.

Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus.

Rådholm K, Figtree G, Perkovic V, Solomon SD, Mahaffey KW, de Zeeuw D, Fulcher G, Barrett TD, Shaw W, Desai M, Matthews DR, Neal B.

Circulation. 2018 Jul 31;138(5):458-468. doi: 10.1161/CIRCULATIONAHA.118.034222.

11.

TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol.

Chow CK, Thiagalingam A, Santo K, Kok C, Thakkar J, Stepien S, Billot L, Jan S, Joshi R, Hillis GS, Brieger D, Chew DP, Rådholm K, Atherton JJ, Bhindi R, Collins N, Coverdale S, Hamilton-Craig C, Kangaharan N, Maiorana A, McGrady M, Shetty P, Thompson P, Rogers A, Redfern J.

BMJ Open. 2018 Jan 27;8(1):e019463. doi: 10.1136/bmjopen-2017-019463.

12.

Blood pressure and all-cause mortality: a prospective study of nursing home residents.

Rådholm K, Festin K, Falk M, Midlöv P, Mölstad S, Östgren CJ.

Age Ageing. 2016 Nov;45(6):826-832. Epub 2016 Jul 18.

PMID:
27496923
13.

[Pre-doc jumpstart for research students].

Rädholm K.

Lakartidningen. 2014 Oct 8-14;111(41):1757. Swedish. No abstract available.

14.

Older age is a strong predictor for poor outcome in intracerebral haemorrhage: the INTERACT2 study.

Rådholm K, Arima H, Lindley RI, Wang J, Tzourio C, Robinson T, Heeley E, Anderson CS, Chalmers J; INTERACT2 Investigators.

Age Ageing. 2015 May;44(3):422-7. doi: 10.1093/ageing/afu198. Epub 2014 Dec 13.

15.

Atrial fibrillation (AF) and co-morbidity in elderly. A population based survey of 85 years old subjects.

Rådholm K, Östgren CJ, Alehagen U, Falk M, Wressle E, Marcusson J, Nägga K.

Arch Gerontol Geriatr. 2011 May-Jun;52(3):e170-5. doi: 10.1016/j.archger.2010.10.024. Epub 2010 Nov 18.

PMID:
21093071

Supplemental Content

Loading ...
Support Center